학술논문
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Document Type
Article
Author
Ascierto, Paolo A ; Del Vecchio, Michele; Mandalá, Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O; Maio, Michele; Middleton, Mark R; de la Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill, Andrew; Fecher, Leslie A; Millward, Michael; Khushalani, Nikhil I; Queirolo, Paola; Lobo, Maurice; de Pril, Veerle; Loffredo, John; Larkin, James; Weber, Jeffrey
Source
In The Lancet Oncology November 2020 21(11):1465-1477
Subject
Language
ISSN
1470-2045